Article
Refine
Year of publication
Institute
- Fachbereich Medizintechnik und Technomathematik (1591)
- Fachbereich Wirtschaftswissenschaften (705)
- Fachbereich Elektrotechnik und Informationstechnik (638)
- Fachbereich Energietechnik (609)
- Fachbereich Chemie und Biotechnologie (602)
- INB - Institut für Nano- und Biotechnologien (542)
- Fachbereich Maschinenbau und Mechatronik (484)
- IfB - Institut für Bioengineering (449)
- Fachbereich Luft- und Raumfahrttechnik (379)
- Fachbereich Bauingenieurwesen (333)
Language
Document Type
- Article (5644) (remove)
Keywords
- Einspielen <Werkstoff> (7)
- Multimediamarkt (6)
- Rapid prototyping (5)
- avalanche (5)
- Earthquake (4)
- FEM (4)
- Finite-Elemente-Methode (4)
- LAPS (4)
- Rapid Prototyping (4)
- biosensors (4)
Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b
(2013)
The contribution of altered post-transcriptional gene silencing to the development of insulin resistance and type 2 diabetes mellitus so far remains elusive. Here, we demonstrate that expression of microRNA (miR)-143 and 145 is upregulated in the liver of genetic and dietary mouse models of obesity. Induced transgenic overexpression of miR-143, but not miR-145, impairs insulin-stimulated AKT activation and glucose homeostasis. Conversely, mice deficient for the miR-143–145 cluster are protected from the development of obesity-associated insulin resistance. Quantitative-mass-spectrometry-based analysis of hepatic protein expression in miR-143-overexpressing mice revealed miR-143-dependent downregulation of oxysterol-binding-protein-related protein (ORP) 8. Reduced ORP8 expression in cultured liver cells impairs the ability of insulin to induce AKT activation, revealing an ORP8-dependent mechanism of AKT regulation. Our experiments provide direct evidence that dysregulated post-transcriptional gene silencing contributes to the development of obesity-induced insulin resistance, and characterize the miR-143–ORP8 pathway as a potential target for the treatment of obesity-associated diabetes.